Citation: New type of insulin that switches on and off could help diabetics avoid sudden drops in blood sugar levels (2024, October 16) retrieved 11 November 2024 from https://medicalxpress.com ...

“Notably, glucose values vary over a narrow range (from approximately 2 to 20-30 mM [36 mg/dL to 360-540 mg/dL] in people with diabetes), so a rather steep change in insulin bioactivity must be ...

Scientists have engineered a modified insulin that reduces its activity at low glucose levels. This glucose-responsive insulin could prevent people with diabetes from experiencing dangerously low ...

Some diabetes patients this year have had trouble finding their preferred insulin brands as major drug manufacturers reported shortages of the medicine. USA TODAY set out to find out what patients ...

A team led by Novo Nordisk’s Rita Slaaby developed the glucose-responsive insulin, which is called NNC2215. The insulin in NNC2215 makes links to two moieties: a glucose-binding macrocycle and a ...

It is the last bullet point that’s creating issues. During the 2023 Open Enrollment Period, I discovered that some clients’ insulin would not be covered by their plans in the new year.

WASHINGTON (Reuters) - Vice President Kamala Harris on the campaign trail has frequently touted capping the price of insulin at $35 a month as a major accomplishment of the Biden administration ...

An Egyptian dog found viral fame after it was filmed frolicking atop one of the pyramids at Giza, spotted by a group of paragliders. Alex Lang, one of the paragliders who filmed the dog ...

But the landmarks don’t usually have dogs hanging out on top of them. While flying over Egypt’s famous Great Pyramids at sunrise earlier this week, US paraglider Marshall Mosher and fellow ...

When it comes to deadly dogs, XL Bullies, Pit bull terriers, or Japanese Tosas might spring to mind. But a shocking incident has highlighted that it's not just these tough looking breeds that can ...

A new treatment combining ReCET and semaglutide eliminated insulin use in 86% of type 2 diabetes patients, improving natural insulin sensitivity. A new treatment combining ReCET and semaglutide could ...